Published July 20, 2017
| Version v1
Patent
Open
USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
- 1. University of Chicago
- 2. Salix Pharmaceuticals
Contributors
Patent applicants:
Description
Presented herein are methods for preventing or treating tumor growth, tumor metastasis and/or abnormal proliferation of tumor cells in a subject, wherein the methods involve administration of a pharmaceutical composition comprising methylnaltrexone. Also presented herein are methods for inhibiting or slowing the growth of a tumor in a subject, wherein the methods include selecting a subject who is a suitable candidate for treatment with methylnaltrexone, and administering a composition comprising methylnaltrexone to the subject.
Files
US20170202832.pdf
Files
(3.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:2a0bd0e94b10e1ab3fa23891fd076696
|
3.1 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201715477724 A
- Patent number
- US 2017/0202832 A1
- Other
- oai:uchicago.tind.io:9484
Dates
- Patent filed
-
2017-04-03